High levels of IL-10 have been reported to be responsible for drug resistance to breast cancer, in which the blockade of this cytokine resulted in diminished STAT3 activation and a decrease in Bcl-2 mRNA expression, and consequently the induction of apoptosis [64]. This evidence concerns the gene BCL2 and breast carcinoma.